Skip To Main Content
Christine Abraham Jaillon on Muck Rack

Christine Abraham Jaillon

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Christine Abraham

Contact Christine Abraham, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Immune checkpoint inhibitors in advanced upper-tract urothelial carcinoma: a multicenter study

|
By Solenn Barraud, Constance Thibault, Valentine Ruste, Aude Flechon, Mostefa Bennamoun, Mathilde Guerin, Hakim Mahammedi, Luca Campedel, Noémie Bigot, Guillaume Mulier, Stéphane Culine, Ronan Flippot, Mathilde Cancel, Clément Dumont, Alexandre Megherbi, Manuela Tiako Meyo, Mathieu Laramas, Aymeric Guilbert, Laurence Crouzet, Christine Abraham Jaillon, Loïc Jaffrelot, Hugo Picchi
| Nature Verified
Abstract To evaluate real-world efficacy of anti-PD-(L)1 immune checkpoint inhibitors (ICIs) in advanced or metastatic upper-tract urothelial carcinoma (mUTUC) and identify clinical and biological factors associated with treatment outcomes, this multicenter retrospective study included 184 adult patients with progressive mUTUC from 16 centers who were treated with single-agent ICIs between 2016 and 2022. Primary endpoint was overall survival (OS).
Open in Who Shared Issue with article?
See all 1 articles